I want to reiterate a few things: A.) No one knows better
I want to reiterate a few things:
A.) No one knows better than me that so many of you are waiting for me to provide my full synopsis of our meeting. I appreciate this. I really do. You must understand that in order for me to get as close to the CEO as I did, I had to agree to certain legal restrictions. I will not, under any circumstances, defy this agreement.
B.) I am aware of some things that as far as I have determined, few, if anyone else is aware of. These things relate directly to the repeated manipulation of the stocks. I am presently awaiting some legal advice on how I can approach this. It is very important that I am made perfectly aware of any repercussions that may arise as a result of my going public with this information. Even if going public means providing the details to select people via email. NOTE: This has nothing to do with any activity by the company. This relates to outside forces.
C.) AS OF MY MEETING WITH DAVID KOOS THERE HAS NOT BEEN AN FDA DENIAL! I will say it again, there has not been a FDA denial. As I have outlined many times, stem cell therapy treatments are relatively new and the FDA is not setup with their required approaches for these treatments as they have been for so long with what is considered traditional treatments. There is no template for this science. Not yet, anyway.
Again, they have not been denied. WHEN THEY ARE APPROVED, I am 99.9% confident that they will be approved with Orphan Drug status.
I welcome all the bashers & flippers to dump their shares. Have at it! But for those of you that understand that this is not something that can happen over night and that there are a lot of loose ends that must be tied up before they can proceed, HOLD TIGHT. My position has not changed. I am long and strong. It is as simple as that. Please stop heeding the words of people who have no clue about what is going on in this company or the FDA process.
RIVULET MEDIA INC. (RIVU) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Top 5 Most Recently Viewed Articles
Crest Surf Clubs Achieves Key Membership Milestone Crest Surf Clubs has reached a notable achievement, with more than 50% of memberships reserved at its flagship location before the official opening. This milestone showcases the growing demand for a unique surf club environment, emphasizing a strong interest in their exclusive surfing experience. Partnership with Wedbush...
Continue Reading
Understanding KBRA's Ratings on PMT Loan Trust 2025-INV2 In a significant move, KBRA has assigned preliminary ratings to 62 classes of mortgage-backed notes from PMT Loan Trust 2025-INV2, also known as PMTLT 2025-INV2. This prime Residential Mortgage-Backed Securities (RMBS) transaction is initiated by PennyMac Corp., which is a wholly-owned subsidiary of PennyMac...
Continue Reading
ImmuCell Strengthens Leadership with New CFO Appointment ImmuCell Corporation (Nasdaq: ICCC), a prominent player in the animal health sector dedicated to improving the well-being of dairy and beef cattle, has taken a significant step forward with the hiring of Timothy C. Fiori as Chief Financial Officer. This strategic recruitment is aimed at bolstering the company’s...
Continue Reading
Overview of the Recombinant Human Hair Keratin Protein Market The recombinant human hair keratin protein market is witnessing a significant surge, propelled by a heightened awareness of hair health and advancements in biotechnology. As companies strive to innovate and meet growing consumer demands, the projected revenues in this sector are expected to reach well into the...
Continue Reading
Transforming Logistics through Innovation ITF Group has forged an exciting partnership with HaulerHub to launch a platform that revolutionizes the connection between shippers and haulers. This innovative platform is designed to bring a thoroughly vetted and verified network of haulers to the forefront, addressing long-standing issues within the logistics industry....
Continue Reading